Enzo BioChem’s sale of its clinical lab business to Labcorp is the culmination of a monthslong strategic review. Meanwhile, diagnostics and lab testing giant Labcorp is in the middle of its own corporate shakeup as it readies its clinical trials business for a spinoff as a standalone, publicly traded company.
Laboratory testing and clinical trial services giant LabCorp plans to spin off its drug development business as an independent, publicly traded company. It’s the latest in a string of corporate moves for the life sciences sector as companies look to streamline operations in order to focus on particular areas of growth.
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
Nuance Communications acquired Saykara, a startup building a medical AI voice assistant to help with charting and other administrative tasks. The deal is expected to build on Nuance's speech recognition tools for physicians.
The agency reissued the emergency use authorization that it gave to LabCorp last month for its RT-PCR test to allow for collection of samples at home by patients, with a doctor's order.
ArQule's lead product candidate is a BTK inhibitor, ARQ-531, designed for heavily pretreated patients with leukemias and lymphomas, particularly those whose disease has become resistant to marketed BTK therapies. Phase I data on the drug were also presented Monday.
A recent survey from Dimensional Insight takes a closer look at the data governance initiatives that hospitals around the United States are implementing, as well as the challenges they face.
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
A group founded by a University of Vermont Medical School pediatrician believes that a smartphone triage tool aimed at community health workers in developing countries could go some ways to reducing preventable child deaths in these areas